as 07-26-2024 4:00pm EST
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Upcoming Earnings Alert:
Get ready for potential market movements as Bio-Rad Laboratories Inc. BIO prepares to release earnings report on 01 Aug 2024.
Founded: | 1952 | Country: | United States |
Employees: | N/A | City: | HERCULES |
Market Cap: | 8.7B | IPO Year: | N/A |
Target Price: | $410.00 | AVG Volume (30 days): | 244.1K |
Analyst Decision: | Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -10.69 | EPS Growth: | N/A |
52 Week Low/High: | $261.59 - $426.74 | Next Earning Date: | 08-01-2024 |
Revenue: | $2,605,238,000 | Revenue Growth: | -6.25% |
Revenue Growth (this year): | 0.25% | Revenue Growth (next year): | 5.27% |
BIO Breaking Stock News: Dive into BIO Ticker-Specific Updates for Smart Investing
Insider Monkey
13 hours ago
Argus Research
3 days ago
Zacks
4 days ago
Business Wire
9 days ago
Argus Research
10 days ago
Argus Research
17 days ago
MT Newswires
a month ago
Zacks
a month ago
The information presented on this page, "BIO Bio-Rad Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.